In this study, we evaluated this CRISPR/nCas9-based gene-editing system to induce the insertion of normal HEXA and HEXB cDNA into the AAVS1 locus on in vitro models of TSD and SD, respectively. This evidence concerns the gene HEXA and Tay-Sachs disease.